Latham Reps Silverfleet In $675M Sterigenics Sale

Law360, New York (February 23, 2011, 6:28 PM EST) -- London-based Silverfleet Capital said Wednesday that it planned to turn a tidy profit from the $675 million sale of medical device and pharmaceuticals sterilization company Sterigenics International Inc. to Chicago private equity firm GTCR LLC.

Silverfleet, along with PM America Capital Partners, bought Sterigenics in 2004 for $311 million, the European midmarket private equity firm said, and since then it has invested more than $100 million to build new facilities in Germany and China.

In September, Sterigenics also said it planned to build a new facility...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.